# Neurock Pharmaceuticals Inc. — Form D

Neurock Pharmaceuticals Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-11. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-03-11
- Form: D
- Accession: 0002014918-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 1
- Date of first sale: 2024-02-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-507160

## Issuer

- Name: Neurock Pharmaceuticals Inc.
- CIK: 0002014918
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 302 CARNEGIE CENTER, SUITE 100, PRINCETON, NJ, 08540
- Phone: 908-926-3116

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Qingxi Wang | Director | Princeton, NJ |
| Lei Cai | Executive Officer | Princeton, NJ |
| Haixing Wang | Executive Officer | Princeton, NJ |

## More

- [CIK 2014918 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2014918&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002014918-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.